These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11125927)

  • 1. Administration of interferon-alpha during pregnancy: effects on fetus.
    Hiratsuka M; Minakami H; Koshizuka S; Sato I
    J Perinat Med; 2000; 28(5):372-6. PubMed ID: 11125927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal lupus and IUGR following alpha-interferon therapy during pregnancy.
    Fritz M; Vats K; Goyal RK
    J Perinatol; 2005 Aug; 25(8):552-4. PubMed ID: 16047033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daily interferon therapy for chronic hepatitis C: a report of a community practice experience.
    Srinivas D; Mani H; Crumpler C; Van Thiel DH
    Hepatogastroenterology; 2002; 49(46):1053-7. PubMed ID: 12143200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon therapy for acute hepatitis C during pregnancy.
    Ozaslan E; Yilmaz R; Simsek H; Tatar G
    Ann Pharmacother; 2002 Nov; 36(11):1715-8. PubMed ID: 12398565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study.
    Bargiggia S; Thorburn D; Anderloni A; Ardizzone S; Giorgi A; Bianchi Porro G; Parente F
    Aliment Pharmacol Ther; 2005 Aug; 22(3):209-15. PubMed ID: 16091058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
    Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
    Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose interferon-alpha 2b plus ribavirin combination therapy for GB virus-C/hepatitis G virus infection--a study in patients with chronic hepatitis C.
    Cheng PN; Jen CM; Young KC; Chen CY; Lu SN; Wang CS; Chang TT
    Hepatogastroenterology; 2003; 50(50):449-52. PubMed ID: 12749244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of seizures 1 week after the cessation of interferon-alpha therapy.
    Seno H; Inagaki T; Itoga M; Miyaoka T; Ishino H
    Psychiatry Clin Neurosci; 1999 Jun; 53(3):417-20. PubMed ID: 10459745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study of combination therapy with initial high-dose interferon and amantadine hydrochloride for patients with chronic hepatitis C with the genotype 1b virus.
    Uyama H; Enomoto H; Kishima Y; Yamamoto M; Yoshida K; Okuda Y; Hirotani T; Kuroda T; Ito H; Matsuda M; Terabayashi M; Noguchi S; Kawase I; Nakamura H
    Hepatogastroenterology; 2003; 50(54):2112-6. PubMed ID: 14696476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased morbidity in severe early intrauterine growth restriction.
    Aucott SW; Donohue PK; Northington FJ
    J Perinatol; 2004 Jul; 24(7):435-40. PubMed ID: 15116139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of natural BALL-1 interferon-alpha treatment for patients with chronic hepatitis C and a possible enhancing effect of a twice-daily starting regimen with interferon-beta.
    Ebinuma H; Saito H; Tada S; Nakamoto N; Kurita S; Kitamaura K; Horikawa H; Kumagai N; Tsuchimoto K; Ishii H; Hibi T;
    Hepatogastroenterology; 2006; 53(67):94-9. PubMed ID: 16506384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of data for 10 children born to mothers who attempted suicide by taking large doses of alprazolam during pregnancy.
    Gidai J; Acs N; Bánhidy F; Czeizel AE
    Toxicol Ind Health; 2008; 24(1-2):53-60. PubMed ID: 18818181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in haemoglobin during interferon alpha-2b plus ribavirin combination therapy for chronic hepatitis C virus infection.
    Sulkowski MS; Wasserman R; Brooks L; Ball L; Gish R
    J Viral Hepat; 2004 May; 11(3):243-50. PubMed ID: 15117326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of prolonged interferon therapy for patients with chronic hepatitis C with HCV-genotype 1b and high virus load.
    Arase Y; Ikeda K; Tsubota A; Suzuki Y; Saitoh S; Kobayashi M; Kobayashi M; Suzuki F; Akuta N; Someya T; Kumada H
    J Gastroenterol; 2003; 38(2):158-63. PubMed ID: 12640530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous interferon-alpha level is increased in hepatitis C virus (HCV)-positive pregnant women.
    Paternoster DM; Belligoli A; Ngaradoumbe NK; Visentin S; Franco R; Fagiuoli S; Boldrin C; Palù G; Baldo V; Floreani A
    J Clin Gastroenterol; 2008 Feb; 42(2):204-7. PubMed ID: 18209593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C.
    Mousa DH; Abdalla AH; Al-Shoail G; Al-Sulaiman MH; Al-Hawas FA; Al-Khader AA
    Transplant Proc; 2004; 36(6):1831-4. PubMed ID: 15350490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term interferon therapy for chronic hepatitis C patients with low viral load.
    Sato Y; Tokuue H; Kawamura N; Nezu-Yajima S; Nakajima H; Ishida H; Takahashi S
    Hepatogastroenterology; 2004; 51(58):968-72. PubMed ID: 15239226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cesarean section on request at 39 weeks: impact on shoulder dystocia, fetal trauma, neonatal encephalopathy, and intrauterine fetal demise.
    Hankins GD; Clark SM; Munn MB
    Semin Perinatol; 2006 Oct; 30(5):276-87. PubMed ID: 17011400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.